Phase 1 Tetanus Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
Diphtheria, Tetanus and Acellular PertussisEpidemic MeningitisHaemophilus Influenzae Type B Infection
CanSino Biologics Inc.260 enrolled1 locationNCT07203755
Recruiting
Phase 1Phase 2
A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
Tetanus-diphtheria-acellular Pertussis (Tdap)
GC Biopharma Corp120 enrolled1 locationNCT06997627
Recruiting
Phase 1
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
DiphtheriaPertussisTetanus
Institute of Medical Biology, Chinese Academy of Medical Sciences460 enrolled3 locationsNCT06184542
Completed
Phase 1
A study to evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Tetanus/Diphtheria/Pertussis Booster Vaccine (Tdap-1018) Compared to Boostrix in Healthy Volunteers Between 10 and 22 Years of Age
DiptheriaPertussisTetanus
Dynavax Technologies Corporation138 enrolled7 locationsACTRN12620001177943